Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierStatistics In System biology and Translational Medicine [SISTM]
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDI MEGLIO, Federico
hal.structure.identifierStatistics In System biology and Translational Medicine [SISTM]
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorLHOMME, Edouard
dc.contributor.authorOUEDRAOGO, Henri Gautier
dc.contributor.authorBARRY, Alpha Mahmoud
dc.contributor.authorDOUMBIA, Seydou
dc.contributor.authorFAYE, Sylvain Landry
dc.contributor.authorMBAWAH, Abdul Karim
dc.contributor.authorSAGNA, Tani
dc.contributor.authorTOUNKARA, Moctar
dc.contributor.authorSTRAUSS, Ricardo
dc.contributor.authorDOUMBIA, Cheick Oumar
dc.contributor.authorDIOUF, Souleymane
dc.contributor.authorCISSÉ, Kadari
dc.contributor.authorMAY, Jürgen
dc.contributor.authorPURADIREDJA, Dewi Ismajani
dc.contributor.authorFUSCO, Daniela
dc.date.accessioned2024-11-25T13:34:16Z
dc.date.available2024-11-25T13:34:16Z
dc.date.issued2024-11-07
dc.identifier.issn2044-6055en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/203472
dc.description.abstractEnThis study aims to identify the factors influencing vaccine hesitancy, willingness and its variation over time in order to inform more responsive strategies for increasing vaccination uptake. The specific objectives are: (1) to describe and compare levels of COVID-19 vaccine hesitancy among the general population in rural and urban settings in West Africa over time and (2) to identify factors associated with COVID-19 vaccination willingness and hesitancy among the general population across five West African countries over time. Following a baseline survey (Wave I), three serial cross-sectional surveys (Waves II-IV) were implemented. The study was conducted in Burkina Faso, Guinea, Mali, Senegal and Sierra Leone from November 2021 to July 2022. A total of 13 571 study participants were included in the study (n=4373, n=4593 and n=4605 for survey Waves II, III and IV, respectively). Inclusion criteria were being 18 years or older, living in the study area and willing to provide informed consent. A two-stage sampling strategy was used to select the sample from among the general population. Primary outcomes were the variability of vaccine hesitancy over time and across the five West African countries. Secondary outcomes were factors associated with vaccine willingness. A small but steady increase in hesitancy to COVID-19-vaccination can be observed across countries, with an upward trend of vaccine hesitancy reported by 952 participants (33.9 %) in Wave II, 1055 (37.3%) in Wave III and 1089 (38.1%) in Wave IV. Among the countries included, Senegal shows the highest level of vaccine hesitancy ('Definitely no' and 'Probably no' ranging from 50.2% to 56.0% and 26.2 to 28.3%, respectively). At the same time, Senegal has the lowest vaccination coverage overall. Across all five countries and survey waves, the primary factor associated with vaccination willingness is fear of experiencing severe COVID-19 disease (Wave II: OR 0.42, 95% CI 0.34 to 0.51, Wave III: OR 0.48, 95% CI 0.40 to 0.59 and Wave IV: OR 0.54, 95% CI 0.44 to 0.66). Perceived improved financial status seems to influence willingness to get vaccinated negatively (OR 0.57, 95% CI 0.40 to 0.81) and unlike in Western, Educated, Industrialised, Rich and Democratic countries, men seem more reluctant to get vaccinated than women (OR 0.77, 95%, CI 0.65 to 0.93). Our findings suggest that vaccine hesitancy should be monitored over time to inform communication strategies, which are responsive to changes in vaccination-related public sentiments. Additionally, a focus on social solidarity and the importance of women in vaccination advocacy can help improve COVID-19 vaccination coverage in West Africa. The general protocol is registered on clinicaltrial.gov (protocol number: NCT04912284).
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/us/*
dc.subject.enAdolescent
dc.subject.enAdult
dc.subject.enFemale
dc.subject.enHumans
dc.subject.enMale
dc.subject.enMiddle Aged
dc.subject.enYoung Adult
dc.subject.enAfrica
dc.subject.enWestern
dc.subject.enCOVID-19
dc.subject.enCOVID-19 Vaccines
dc.subject.enCross-Sectional Studies
dc.subject.enPatient Acceptance of Health Care
dc.subject.enSurveys and Questionnaires
dc.subject.enVaccination Hesitancy
dc.title.enVariations in COVID-19 vaccine hesitancy over time: a serial cross-sectional study in five West African countries
dc.title.alternativeBMJ Openen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1136/bmjopen-2023-083766en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed39510778en_US
bordeaux.journalBMJ Openen_US
bordeaux.pagee083766en_US
bordeaux.volume14en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue11en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.institutionINRIAen_US
bordeaux.teamSISTM_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcepubmed
hal.identifierhal-04802489
hal.version1
hal.date.transferred2024-11-25T13:34:21Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=BMJ%20Open&rft.date=2024-11-07&rft.volume=14&rft.issue=11&rft.spage=e083766&rft.epage=e083766&rft.eissn=2044-6055&rft.issn=2044-6055&rft.au=DI%20MEGLIO,%20Federico&LHOMME,%20Edouard&OUEDRAOGO,%20Henri%20Gautier&BARRY,%20Alpha%20Mahmoud&DOUMBIA,%20Seydou&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée